AICommittee markup of insulin pricing, price transparency, and food safety bills

Health Care Costs and Drug PricingSenate Health, Education, Labor, and Pensions · 2026-07-22 · 119th Congress
The Senate Committee on Health, Education, Labor, and Pensions convened this business meeting to mark up eleven bipartisan bills covering hospital and insurer price transparency, insulin cost caps, biosimilar drug approval, food and drug safety, nursing workforce shortages, obstetric emergency care, and warning labels on ultra-processed foods and sugary drinks. Begins at 0:16:28
Transcript
Highlights

Title

Committee markup of insulin pricing, price transparency, and food safety bills

Purpose

The Senate Committee on Health, Education, Labor, and Pensions convened this business meeting to mark up eleven bipartisan bills covering hospital and insurer price transparency, insulin cost caps, biosimilar drug approval, food and drug safety, nursing workforce shortages, obstetric emergency care, and warning labels on ultra-processed foods and sugary drinks. Chair Cassidy framed the session around lowering health care costs for families and thanked staff for months of bipartisan negotiation on each bill. Nearly every bill was amended and reported favorably by roll-call or voice vote. Begins at0:16:28

Who spoke

Chair Bill Cassidy (R-LA)0:16:28: Opened by describing high deductibles and unaffordable premiums for the 62% of Americans insured through small businesses0:16:57, previewed all eleven bills including a $35 insulin cap and price transparency legislation0:18:16, and chaired every subsequent vote and amendment debate through adjournment1:55:10.

Sen. Bernie Sanders (I-VT), Ranking Member0:22:07: Argued health care is a human right and the U.S. spends nearly double other nations while 85 million Americans are underinsured0:23:05; detailed his Childhood Diabetes Reduction Act, citing $400 billion in annual U.S. diabetes costs and 73% of the food supply being ultra-processed0:24:330:26:07; opposed Sen. Paul's SNAP amendment as stigmatizing poor children1:36:57.

Sen. Rand Paul (R-KY)0:31:04: Presented his biosimilars bill, noting biologics are 5% of prescriptions but 51% of spending0:31:04; opposed the insulin price cap, comparing price controls to shortages in Venezuela and the Soviet Union0:36:44; argued price-transparency mandates won't change fixed Medicare or insurance prices0:52:12; offered an amendment to bar SNAP purchases of candy and soda1:34:38.

Sen. Susan Collins (R-ME)0:33:48: Detailed the Insulin Act's $35 monthly cap and cited nearly 40% of diabetics rationing insulin due to cost0:34:49; described a constituent from Chelsea, Maine hospitalized after skipping doses0:35:19; later opposed Sanders' junk-food labeling bill over food-cost and school-nutrition concerns1:31:09; championed the nursing workforce and rural obstetrics bills, citing Maine's severe nurse shortage1:10:281:26:17.

Sen. Tim Kaine (D-VA) [0:56:20 area, no direct quote]: Not separately quoted with distinct claims beyond co-sponsorship credit; omitted as non-speaking in transcript.

Sen. Tammy Baldwin (D-WI)0:38:18: Offered the Baldwin-Collins insulin amendment restoring a $35 pilot program for uninsured patients0:38:43, which was adopted 12-100:46:16; later withdrew a natural-cheese-definition (CURD Act) amendment0:57:22; opposed the diabetes labeling bill over dairy-product mislabeling concerns1:54:05.

Sen. Roger Marshall (R-KS)0:47:29: Championed the Patients Deserve Price Tags Act, citing wide price variation such as $15,000 vs. $80,000 hip replacements0:48:58; supported Sanders' diabetes bill despite reservations, saying "desperate times call for desperate measures"1:33:14.

Sen. John Hickenlooper (D-CO)0:49:41: Said Americans spent $5.7 trillion on health care in 2025 with 121% health inflation growth over 25 years0:50:13, and estimated 25% of health spending is waste, with even 10% legitimate reduction saving hundreds of billions0:50:43.

Sen. Tommy Tuberville (R-AL)0:54:46: Presented the Make Americans Food Safer Act, explaining it lets FDA destroy and share data on unsafe food imports at ports0:55:18.

Sen. Maggie Hassan (D-NH)1:00:32: Raised national security concerns about publicly listing exact drug manufacturing locations under the Clear Labels Act1:00:32; championed the Rural Obstetrics Readiness Act, describing maternal health care deserts1:25:07.

Sen. Jim Banks (R-IN)1:04:10: Presented the Safe Drugs Act requiring compounding pharmacies to report adverse events, citing journalist exposés of dangerous conditions at some facilities1:04:36.

Sen. Jon Husted (R-OH)1:05:34: Offered (then withdrew) an amendment to expedite FDA approval for over-the-counter drug conversions, citing $7.33 in system savings per dollar spent on OTC drugs1:06:13; later offered a tabled amendment requiring cost-impact review before diabetes-bill labeling takes effect1:41:35.

Sen. Lisa Blunt Rochester (D-DE)1:11:26: Offered amendments to the nursing workforce bill creating a state nursing workforce center pilot program1:12:55 and, on Sen. Murkowski's behalf, a nursing faculty shortage demonstration grant citing 92,672 qualified applicants turned away from nursing schools1:17:31; both adopted by voice vote.

Key moments

Sanders cited that Coca-Cola spent over $5 billion on advertising while earning $11 billion in profits, and that a 20-ounce Coke contains over 15 teaspoons of sugar, more than double the recommended daily limit for kids0:27:31.

Baldwin's insulin amendment restoring a $35/month pilot for uninsured patients was initially declared not tabled on a 10-12 vote0:44:44, then adopted 12-10 on final vote despite Cassidy's opposition, who called it "a money grab" against 340B program intent0:41:430:46:16.

Sharp disagreement between Paul and the committee majority on price controls: Paul argued fixed Medicare and insurance prices mean transparency mandates "won't help"0:52:42, while Marshall countered with real-world examples of MRI prices ranging from $300 to $3,000 for the same procedure0:48:58.

Paul's SNAP amendment to bar candy and soda purchases, informed by data showing Coca-Cola/Pepsi as the top SNAP purchase category and candy at #11, was tabled 16-6 after Sanders argued it would stigmatize low-income children1:35:081:41:08.

Collins and Sanders disagreed sharply over the Childhood Diabetes Reduction Act: Collins warned it could require warning labels on yogurt, cheese, and potatoes and said diabetes advocacy groups had not endorsed it1:31:40, while Sanders countered the bill exempts FDA-defined "healthy" foods including dairy1:32:34.

Husted's amendment requiring proof the diabetes bill wouldn't raise food costs was called a "poison pill" designed to further delay warning labels by Sanders1:42:13, and was tabled by voice vote over Collins, Hawley, Husted, and Banks's recorded no votes1:43:38.

The insulin bill (S.4189) passed committee 18-4, with Cassidy himself voting no despite supporting the "core policy," reflecting internal GOP division1:51:170:39:35.

A batch of five bills — Patients Deserve Price Tags Act, Clear Labels Act, Empower for Health Act, Title VIII Nursing Workforce Reauthorization Act, and Rural Obstetrics Readiness Act — passed together 21-11:48:04.

Collins noted rural Mainers must drive more than 45 minutes on average to the nearest birthing hospital, and about half of Maine's hospitals lack dedicated labor and delivery units1:26:50.

The Safe Drugs Act (S.3794) for compounding pharmacies passed narrowly by a margin described as close, following Banks's citation of investigative journalism exposing "terrible conditions and dangerous products" at some facilities1:04:36.

Metadata

Official titleBusiness meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care.
CommitteeSenate Health, Education, Labor, and Pensions
Chamber / CongressSenate · 119th Congress
Date2026-07-22
TypeOpen Business Meeting
Witnesses
(none listed in event metadata)
Videosenate-isvp
Transcript304 caption blocks · 13,067 words · 1:55:30 runtime
EventCongress.gov 338667